An orally bioavailable inhibitor of mitochondrial complex I
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

IACS-010759

Item No. 25867

Technical Information
Formal Name
4-(methylsulfonyl)-1-[3-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1H-1,2,4-triazol-1-yl]methyl]phenyl]-piperidine
CAS Number
1570496-34-2
Molecular Formula
C25H25F3N6O4S
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 0.1 mg/mlDMSO: 0.2 mg/mlEthanol: Slightly soluble
λmax
244 nm
SMILES
CS(C1CCN(C2=CC=CC(CN3C(C)=NC(C4=NC(C5=CC=C(OC(F)(F)F)C=C5)=NO4)=N3)=C2)CC1)(=O)=O
InChi Code
InChI=1S/C25H25F3N6O4S/c1-16-29-23(24-30-22(32-38-24)18-6-8-20(9-7-18)37-25(26,27)28)31-34(16)15-17-4-3-5-19(14-17)33-12-10-21(11-13-33)39(2,35)36/h3-9,14,21H,10-13,15H2,1-2H3
InChi Key
HWJWNWZJUYCGKV-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    IACS-010759 is an orally bioavailable inhibitor of complex I of the mitochondrial electron transport chain.1,2 It inhibits the ubiquinone reduction activity of isolated murine mitochondrial complex I when used at a concentration of 60 nM.1 IACS-010759 (100 nM) reduces basal and spare respiratory capacities and increases glycolytic flux in primary chronic lymphocytic leukemia (CLL) cells.2 It also induces apoptosis in CLL cells grown under low glucose conditions or when administered in combination with 2-deoxy-D-glucose (Item No. 14325). IACS-010759 (5 and 10 mg/ml) induces tumor regression in a glycolysis-deficient NB1 mouse xenograft model.1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Molina, J.R., Sun, Y., Protopopova, M., et alAn inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat. Med. 24(7), 1036-1046 (2018).

    2. Vangapandu, H.V., Alston, B., Morse, J., et alBiological and metabolic effects of IACS-010759, an OxPhos inhibitor, on chronic lymphocytic leukemia cells. Oncotarget 9(38), 24980-24991 (2018).